Daniel Ramirez

Vice President Operations, Site Head at Cellipont Bioservices

Daniel Ramirez has extensive work experience in the pharmaceutical and biotechnology industries. Daniel is currently working at Cellipont Bioservices as the Sr. Director of Operations & Site Lead. Prior to this, they held multiple roles at Catalent Pharma Solutions, including Director, Manufacturing Science & Technology (MS&T), Director Of Manufacturing, Commercial Operations Manager, and Manager, Manufacturing Sciences & Technology (MS&T).

Before joining Catalent Pharma Solutions, they worked at Goodwin Biotechnology, Inc. as a Senior Process Engineer & Group Leader (MS&T).

Daniel began their career at the Center of Molecular Immunology as a Senior Supervisor, Downstream Manufacturing.

Overall, they have gained extensive experience in various aspects of operations, manufacturing, and technology within the pharmaceutical and biotechnology sectors.

Daniel Ramirez's education history includes the following:

From 2021 to 2023, Daniel is pursuing a Master's degree in Biotechnology at Johns Hopkins University Advanced Academic Programs.

In 2019 and 2020, Daniel received a CORe Credential of Readiness from Harvard Business School Online. The field of study for this credential is not specified.

Between 2007 and 2013, Daniel earned a Bachelor's degree in Chemical Engineering from Universidad Tecnológica de La Habana "José Antonio Echeverría", CUJAE.

In terms of additional certifications, in June 2021, Daniel obtained a Lean Six Sigma Yellow Belt Certification from MoreSteam. Furthermore, in September 2020, Daniel obtained a Verified International Academic Qualifications certification from World Education Services.

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Cellipont Bioservices

Cellipont Bioservices is a cell therapy CDMO with more than 15 years’ experience in the development and small-to-large batch manufacturing of cell therapies. Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients to expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities.   We are a small company with a culture that is extremely responsive and customer-centric. Despite our size, Cellipont Bioservices has very deep technical experience, including 18,000+ tissue samples and more than 900 primary cell cultures. With decades of experience at advanced therapy service companies large and small, our leadership team is guiding Cellipont’s growth with deep knowledge of what it takes succeed in this space.   Cellipont Bioservices facilities and quality systems are GMP-compliant and we hold a California Food & Drug Branch manufacturing license. We have extensive experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches. OUR NAME: By combining “cell” with the latin root for bridge (pont), the name Cellipont Bioservices reflects several dimensions of what we are all about: we bridge our innovator clients with patients; we bridge technical excellence and personal service; and for our team, we bridge personal passion with professional vocation. As we finalize our corporate rebranding, we look forward to launching a new website in the coming weeks to better share our vision with you.


Employees

51-200

Links